Apitolisib
Information
- Drug Name
- Apitolisib
- Description
- Entry(CIViC)
- 3
CIViC
Disease | Mutation | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
head and neck squamous cell carcinoma |
PIK3CA p.Glu542Lys (p.E542K) ( ENST00000643187.1, ENST00000263967.4 ) PIK3CA p.Glu542Lys (p.E542K) ( ENST00000263967.4, ENST00000643187.1 ) |
C |
![]() |
![]() |
Sensitivity/Response | Somatic | 2 | 26787751 | Detail |
cancer |
PIK3CA p.Glu545Lys (p.E545K) ( ENST00000263967.4, ENST00000643187.1 ) PIK3CA p.Glu545Lys (p.E545K) ( ENST00000263967.4, ENST00000643187.1 ) |
C |
![]() |
![]() |
Sensitivity/Response | Somatic | 1 | 26787751 | Detail |
malignant mesothelioma | BAP1 ALTERNATIVE TRANSCRIPT (ATI) BAP1 ALTERNATIVE TRANSCRIPT (ATI) | D |
![]() |
![]() |
Sensitivity/Response | Somatic | 3 | 28389374 | Detail |
Annotation
Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
---|---|---|---|---|---|---|
Phase 1 study with the dual PI3K/mTOR inhibitor ap... | PIK3CA |
PIK3CA p.Glu542Lys (p.E542K) ( ENST00000643187.1, ENST00000263967.4 ) PIK3CA p.Glu542Lys (p.E542K) ( ENST00000263967.4, ENST00000643187.1 ) |
Sensitivity | true | CIViC Evidence | detail |
Phase 1 study with the dual PI3K/mTOR inhibitor ap... | PIK3CA |
PIK3CA p.Glu545Lys (p.E545K) ( ENST00000263967.4, ENST00000643187.1 ) PIK3CA p.Glu545Lys (p.E545K) ( ENST00000263967.4, ENST00000643187.1 ) |
Sensitivity | true | CIViC Evidence | detail |
Novel alternative splice isoform of BAP1 (BAP1Δ) t... | BAP1 | BAP1 ALTERNATIVE TRANSCRIPT (ATI) BAP1 ALTERNATIVE TRANSCRIPT (ATI) | Sensitivity | true | CIViC Evidence | detail |
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT01485861 | Completed | Phase 1/Phase 2 | Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy | January 11, 2012 | August 31, 2022 |
- Target (Drug list of Screening Committee of Anticancer Drugs)
- Phosphoinositide 3-kinase (PI3K)
- Synonym (Drug list of Screening Committee of Anticancer Drugs)
- GDC-0980
- Synonym (Drug list of Screening Committee of Anticancer Drugs)
- RG7422
- Target (Drug list of Screening Committee of Anticancer Drugs)
- mTOR
- Synonym (Drug list of Screening Committee of Anticancer Drugs)
- GDC-0980
- Synonym (Drug list of Screening Committee of Anticancer Drugs)
- RG7422